Merck expands CRISPR patent portfolio
12-05-2020
USITC investigates grey market IVF products
14-04-2020
Merck KGaA secures CRISPR patents in Japan and Singapore
27-11-2019
Vchal / Shutterstock.com
Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Merck KGaA, CRISPR, MilliporeSigma, patent, gene-editing, genetics, Udit Batra, genome
